Efficacy of Liquid Biopsies Using Extracellular Vesicles for Patients with PDAC
In this interview Dr. Harmeet Dhani, MD, MSc, of Biological Dynamics, highlights his recent publication in Communications Medicine on the benefits of liquid biopsies and why the study investigated the potential of extracellular vesicles protein biomarkers as a detection method for pancreatic cancer. Dr. Dhani also discusses how the study incorporated machine learning and what information was used in the algorithm to help detect PDAC.
The ExoVerita™ Pro instrument and ExoVita™ Pancreas test described is for Research Use Only. Not for diagnostic purposes.
Biological Dynamics’s Clinical Laboratory is CLIA-certified and CAP accredited.
©2024 Biological Dynamics